Cerus Company Insiders

CERS Stock  USD 1.45  0.00  0.00%   
Cerus' insiders are aggressively selling. The analysis of insiders' sentiment of trading Cerus stock suggests that vertually all insiders are panicking at this time. Cerus employs about 614 people. The company is managed by 18 executives with a total tenure of roughly 76 years, averaging almost 4.0 years of service per executive, having 34.11 employees per reported executive.
William Greenman  CEO
CEO and President and Director
Laurence Corash  President
Senior Vice President Chief Medical and Chief Scientific Officer, Director

Insider Sentiment 0

 Mostly Selling

 
Selling
 
Buying

Latest Trades

2025-03-13William Mariner GreenmanDisposed 71086 @ 1.45View
2025-03-07William Mariner GreenmanDisposed 60984 @ 1.5View
2025-03-04William Mariner GreenmanDisposed 23023 @ 1.55View
2025-03-03Kevin Dennis GreenDisposed 60656 @ 1.58View
2024-12-12Eric BjerkholtDisposed 20000 @ 1.78View
2024-09-03Kevin Dennis GreenDisposed 28385 @ 2.18View
2024-08-02Richard J BenjaminDisposed 21605 @ 2.5View
Monitoring Cerus' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cerus. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Cerus Stock please use our How to Invest in Cerus guide.

Cerus Management Team Effectiveness

The company has return on total asset (ROA) of (0.0382) % which means that it has lost $0.0382 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3569) %, meaning that it created substantial loss on money invested by shareholders. Cerus' management efficiency ratios could be used to measure how well Cerus manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.11 in 2025. Return On Capital Employed is likely to drop to -0.11 in 2025. At this time, Cerus' Non Current Assets Total are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 33.6 M in 2025, whereas Total Current Assets are likely to drop slightly above 101.9 M in 2025.
Common Stock Shares Outstanding is likely to gain to about 193.8 M in 2025, whereas Net Loss is likely to drop (40.4 M) in 2025.

Cerus Workforce Comparison

Cerus is rated fifth in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 8,408. Cerus holds roughly 614 in number of employees claiming about 7% of equities under Health Care industry.

Cerus Profit Margins

The company has Profit Margin (PM) of (0.1) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.14) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.14.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.680.5521
Fairly Up
Very volatile

Cerus Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cerus insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cerus' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Cerus insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Cerus Notable Stakeholders

A Cerus stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Cerus often face trade-offs trying to please all of them. Cerus' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Cerus' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Laurence MDCoFounder OfficerProfile
William GreenmanCEO and President and DirectorProfile
Laurence CorashSenior Vice President Chief Medical and Chief Scientific Officer, DirectorProfile
Kevin GreenCFO and VP of Fin.Profile
Kevin CPAVP CFOProfile
Carol MooreSr. VP of Regulatory Affairs, Quality and ClinicalProfile
Lainie CortenSr. Director, Global Marketing & Investor RelationsProfile
Lori RollVP SecretaryProfile
Matthew NotarianniDirector RelationsProfile
Richard BenjaminChief Medical OfficerProfile
Vivek JayaramanChief Commercial OfficerProfile
Chrystal JensenChief CounselProfile
Jessica HanoverVice AffairsProfile
Chrystal MenardChief Legal OfficerProfile
Dr MBChBChief OfficerProfile
Alicia GoodmanChief OfficerProfile
Chrystal JDGeneral OfficerProfile
Nina MuftiSenior DevelopmentProfile

About Cerus Management Performance

The success or failure of an entity such as Cerus often depends on how effective the management is. Cerus management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Cerus management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Cerus management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.10)(0.11)
Return On Capital Employed(0.10)(0.11)
Return On Assets(0.10)(0.11)
Return On Equity(0.37)(0.39)
Please note, the imprecision that can be found in Cerus' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Cerus. Check Cerus' Beneish M Score to see the likelihood of Cerus' management manipulating its earnings.

Cerus Workforce Analysis

Traditionally, organizations such as Cerus use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Cerus within its industry.

Cerus Manpower Efficiency

Return on Cerus Manpower

Revenue Per Employee293.6K
Revenue Per Executive10M
Net Loss Per Employee34.1K
Net Loss Per Executive1.2M
Working Capital Per Employee144K
Working Capital Per Executive4.9M

Additional Tools for Cerus Stock Analysis

When running Cerus' price analysis, check to measure Cerus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cerus is operating at the current time. Most of Cerus' value examination focuses on studying past and present price action to predict the probability of Cerus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cerus' price. Additionally, you may evaluate how the addition of Cerus to your portfolios can decrease your overall portfolio volatility.